Feedback / Questions
atomoxetine/R-oxybutynin (AD109) - Apnimed
https://www.businesswire.com/news/home/20200917005081/en/Apnimed-Successfully-Completes-Phase-1-Study-in-Lead-Program-for-Obstructive-Sleep-Apnea
Sep 17, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next